Undoctored vault view

Te Pātaka Whaioranga - Pharmac has today confirmed that it will be funding seven new medicines and widening access to another two already funded medicines, with thousands of New Zealanders expected to benefit

Community based alcohol and drugs services in Otago will soon be expanding with an innovative new service to be run by Te Kāika

BiomeBank today announced the first regulatory approval for a donor derived microbiome drug product worldwide

“The best news for allergy sufferers in 25 years” is how Allergy New Zealand’s Chief Executive is describing today’s announcement that Pharmac will consult on funding adrenaline auto injectors for those who need them

Te Pātaka Whaioranga – Pharmac has announced today that all young tamariki will receive access to the PCV13 pneumococcal vaccine (brand name Prevenar 13) as part of the childhood immunisation programme, instead of the currently funded PCV10 vaccine (brand name Synflorix). PCV13 vaccine is currently only funded for high-risk individuals

The NZ Drug Foundation says a 54% increase in drug overdose deaths between 2017 and 2021 is deeply concerning and must prompt swift action on lifesaving preventative measures

The new formulation of Bonjela for infants  has been listed as a medical device with Medsafe and it is available to consumers now for infants aged over six months through supermarkets and pharmacies

Today Pharmac released a discussion paper titled Funding of Paediatric Cancer Treatments in New Zealand

Te Pātaka Whaioranga Pharmac is seeking feedback on rule 8.1b of the Pharmaceutical Schedule – a unique exception that means any medicine currently used to treat cancer in a paediatric setting is automatically funded without a Pharmac assessment